Viewing Study NCT00763568


Ignite Creation Date: 2025-12-17 @ 3:21 PM
Ignite Modification Date: 2025-12-23 @ 4:53 PM
Study NCT ID: NCT00763568
Status:
Last Update Posted:
First Post:
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: 4-Week Lead-In With Nitazoxanide Followed by 36 Weeks Nitazoxanide and Peginterferon Alfa-2a in Chronic Hepatitis C
Sponsor:
Organization:

Study Modules

Contacts Locations Module Design Module Eligibility Module Outcomes Module References Module